360 High-Risk Vulnerability Immunization Tool V2.0 vs eScan Endpoint Security: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros & cons — compared head-to-head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). eScan Endpoint Security is a free endpoint protection platform tool. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
SMBs and cost-conscious mid-market teams with budget constraints should consider eScan Endpoint Security for its free tier, which includes real-time scanning and firewall capabilities without licensing friction. The platform holds ISO 27001 certification and deploys via lightweight agents that don't bog down older hardware, a practical advantage for organizations running mixed-generation endpoint fleets. Skip this if you need advanced threat hunting or behavioral analytics; eScan prioritizes prevention and signature-based detection over investigative depth, which limits incident response capabilities for security teams handling sophisticated threats.
